Everand Logo

Welcome to Everand!

  • STAT

    Columbia’s dismissal of prominent neuroscientist prompts demand for answers

    Columbia University students and postdoctoral fellows are urging administrators to specify why they closed a prominent neuroscientist's lab and ended his administrative positions.
    by Sharon Begley and Andrew Joseph Mar 12, 2018 3 minutes
    Neuroscientist Thomas Jessell

    Dozens of current and former students and postdoctoral fellows at Columbia University are urging administrators to specify why the school announced last week that it would close the lab of prominent neuroscientist Thomas Jessell and end his administrative positions.

    Columbia has declined to offer any explanation for Jessell’s removal beyond a terse statement that said an investigation had “revealed serious violations of University policies and values governing the behavior of faculty members in an academic environment.” That statement, current and former students say in an , has

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About MDMA For PTSD, A CRISPR Treatment For Blindness, And More
    An FDA advisory panel will deliberate on June 4 whether to recommend approval for the first MDMA-assisted therapy for post-traumatic stress disorder.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
    MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
    Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.

    Related Books & Audiobooks